Review of clinical trials for mitochondrial disorders: 1997-2012.
about
Mitochondrial disorders in children: toward development of small-molecule treatment strategiesThe Therapeutic Potential of the Ketogenic Diet in Treating Progressive Multiple SclerosisPrimary Mitochondrial Disease and Secondary Mitochondrial Dysfunction: Importance of Distinction for Diagnosis and TreatmentNeuroglobin gene therapy prevents optic atrophy and preserves durably visual function in Harlequin mice.Degree of glutathione deficiency and redox imbalance depend on subtype of mitochondrial disease and clinical status.Sodium dichloroacetate exhibits anti-leukemic activity in B-chronic lymphocytic leukemia (B-CLL) and synergizes with the p53 activator Nutlin-3.Regulation of substrate utilization by the mitochondrial pyruvate carrierYeast as a system for modeling mitochondrial disease mechanisms and discovering therapies.Potential compounds for the treatment of mitochondrial disease.Mitochondrial Dysfunction Plus High-Sugar Diet Provokes a Metabolic Crisis That Inhibits GrowthInhibiting cytosolic translation and autophagy improves health in mitochondrial disease.Zebrafish lacking functional DNA polymerase gamma survive to juvenile stage, despite rapid and sustained mitochondrial DNA depletion, altered energetics and growthEmerging therapies for mitochondrial disorders.Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society.Development of pharmacological strategies for mitochondrial disorders.Emerging aspects of treatment in mitochondrial disorders.Targeting autophagy and mitophagy for mitochondrial diseases treatment.Inherited mitochondrial genomic instability and chemical exposures.Drug development challenges and strategies to address emerging and resistant fungal pathogens.Nutritional interventions in primary mitochondrial disorders: Developing an evidence base.Therapeutic strategies for Leber's hereditary optic neuropathy: A current update.Depleted energy charge and increased pulmonary endothelial permeability induced by mitochondrial complex I inhibition are mitigated by coenzyme Q1 in the isolated perfused rat lungQuantifying small molecule phenotypic effects using mitochondrial morpho-functional fingerprinting and machine learning.Estimating the occurrence of primary ubiquinone deficiency by analysis of large-scale sequencing data.Clinical utility of exome sequencing in individuals with large homozygous regions detected by chromosomal microarray analysis.Randomized dose-escalation trial of elamipretide in adults with primary mitochondrial myopathy.Mitochondrial disease patient motivations and barriers to participate in clinical trials.Advances in therapeutic strategies for Leber’s hereditary optic neuropathyMultiple Symmetric Lipomatosis (Madelung Disease) in a Large Canadian Family With the Mitochondrial c.8344A>G Variant
P2860
Q26767327-C127F8AB-8430-43E9-84DC-C71EB2D23E79Q26769966-A5BCE87D-BB88-4B1E-AB5C-D44456EAF3D1Q28078384-DD289572-2731-46F6-8E03-F124124B7A8DQ33724242-2A55493B-693C-4EE4-B5FA-9AB2ED0D0DBFQ33773866-FDDA12D2-1AA0-4D0B-BDFD-3C1B8AB64DDAQ34100963-32667EEE-6729-4F9B-B6D6-EFC11B7CE66FQ34710980-B431897E-F20D-488E-8637-952B991B2C2AQ35687142-0A574507-94AD-47EC-B7B0-612E71EBEA9CQ35847813-FC24844F-2AA5-4005-8502-A878F40BF2EBQ35904888-525F0C11-ECE2-4066-9392-0F5D6298B614Q35924054-29C559EA-13AA-46EA-A19E-BD086CE5729CQ36337679-68A23A23-8F64-41D1-BC91-53BC5CB40F36Q36967723-C21B0C1C-8A8E-4B5D-A237-2BCAFF772104Q37210464-4E9657C7-2518-4102-8427-54D1BE64925FQ37686237-6A75737F-3D8B-4D1C-A351-CCAB634E9FACQ38472989-C0C9B611-C2D1-45D6-884E-08740B28DC5AQ38622293-739B4DB5-D76A-4EC6-BE88-1005406C5B31Q38649815-6642F037-A693-4895-A4B2-CBC79037CD6FQ38798805-67CFF73B-8FC5-42BF-8DE7-286EA2DB090CQ38963725-B4B3ACAE-3AB4-4FDB-9E0F-3EBAF851D08AQ39108502-6C5021F1-27B4-4F78-BB8C-657C662EAC7CQ41956015-4F2DDBE0-0C9C-4FE5-9121-7C0B146DDBAEQ42760711-41935F4D-9D85-43EB-93E4-B8CD71593D68Q47159524-B0B21399-22A0-475E-B1FF-8E158FA6C703Q52648403-BA63CFDC-1342-4E79-86E5-1EEE5CB62AA9Q55234371-8E1A3B59-3180-4078-870B-F6C4E41CBE67Q55313136-65345CBD-4953-44C8-BE77-F5A1810FFAA3Q55982429-F4C7307E-50C3-4B2F-9D64-C5902F9ECD03Q57065241-14534CF2-56F3-4915-9C8A-D1EB63AA897E
P2860
Review of clinical trials for mitochondrial disorders: 1997-2012.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Review of clinical trials for mitochondrial disorders: 1997-2012.
@ast
Review of clinical trials for mitochondrial disorders: 1997-2012.
@en
type
label
Review of clinical trials for mitochondrial disorders: 1997-2012.
@ast
Review of clinical trials for mitochondrial disorders: 1997-2012.
@en
prefLabel
Review of clinical trials for mitochondrial disorders: 1997-2012.
@ast
Review of clinical trials for mitochondrial disorders: 1997-2012.
@en
P2860
P1433
P1476
Review of clinical trials for mitochondrial disorders: 1997-2012.
@en
P2093
Douglas S Kerr
P2860
P2888
P304
P356
10.1007/S13311-013-0176-7
P577
2013-04-01T00:00:00Z